These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2782400)

  • 21. Studies in type I glycogenosis of the liver. The genesis and disposition of lactate.
    Sadeghi-Nejad A; Presente E; Binkiewicz A; Senior B
    J Pediatr; 1974 Jul; 85(1):49-54. PubMed ID: 4527989
    [No Abstract]   [Full Text] [Related]  

  • 22. Glucose isotope, carbon recycling, and gluconeogenesis using [U-13C]glucose and mass isotopomer analysis.
    Lee WN; Sorou S; Bergner EA
    Biochem Med Metab Biol; 1991 Jun; 45(3):298-309. PubMed ID: 2049183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia.
    Hijmans BS; Boss A; van Dijk TH; Soty M; Wolters H; Mutel E; Groen AK; Derks TGJ; Mithieux G; Heerschap A; Reijngoud DJ; Rajas F; Oosterveer MH
    Hepatology; 2017 Dec; 66(6):2042-2054. PubMed ID: 28727166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycogen storage disease in Israel. A clinical, biochemical and genetic study.
    Levin S; Moses SW; Chayoth R; Jagoda N; Steinitz K
    Isr J Med Sci; 1967; 3(3):397-410. PubMed ID: 5317551
    [No Abstract]   [Full Text] [Related]  

  • 25. Growth and endocrine changes in the hepatic glycogenoses.
    Dunger DB; Holder AT; Leonard JV; Okae J; Preece MA
    Eur J Pediatr; 1982 May; 138(3):226-30. PubMed ID: 6749505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic ultrasound findings in the glycogen storage diseases.
    Lee P; Mather S; Owens C; Leonard J; Dicks-Mireaux C
    Br J Radiol; 1994 Nov; 67(803):1062-6. PubMed ID: 7820397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Continuous nocturnal intragastric feeding in glycogenosis type I and III].
    de Parscau L; Guibaud P; Hermier M; François R
    Pediatrie; 1986; 41(3):197-203. PubMed ID: 3095784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isotopic measurement of glucose and lactate kinetics.
    Wolfe RR
    Ann Med; 1990 Jun; 22(3):163-70. PubMed ID: 2393551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass and positional isotopomer analysis of glucose metabolism in periportal and pericentral hepatocytes.
    Cline GW; Shulman GI
    J Biol Chem; 1995 Nov; 270(47):28062-7. PubMed ID: 7499292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of liver glycogen repletion in vivo by nuclear magnetic resonance spectroscopy.
    Shulman GI; Rothman DL; Smith D; Johnson CM; Blair JB; Shulman RG; DeFronzo RA
    J Clin Invest; 1985 Sep; 76(3):1229-36. PubMed ID: 4044833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diet and growth of children with glycogen storage disease Types I and III.
    Daeschel IE; Janick LS; Kramish MJ; Coleman RA
    J Am Diet Assoc; 1983 Aug; 83(2):135-41. PubMed ID: 6409953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring.
    Halaby CA; Young SP; Austin S; Stefanescu E; Bali D; Clinton LK; Smith B; Pendyal S; Upadia J; Schooler GR; Mavis AM; Kishnani PS
    Genet Med; 2019 Dec; 21(12):2686-2694. PubMed ID: 31263214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of liver glycogenoses, with particular reference to the metabolism of intravenously administered glycerol.
    Senior B; Loridan L
    N Engl J Med; 1968 Oct; 279(18):958-65. PubMed ID: 4300572
    [No Abstract]   [Full Text] [Related]  

  • 35. Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases.
    Sluiter W; van den Bosch JC; Goudriaan DA; van Gelder CM; de Vries JM; Huijmans JG; Reuser AJ; van der Ploeg AT; Ruijter GJ
    Clin Chem; 2012 Jul; 58(7):1139-47. PubMed ID: 22623745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal rate of enteral glucose administration in children with glycogen storage disease type I.
    Schwenk WF; Haymond MW
    N Engl J Med; 1986 Mar; 314(11):682-5. PubMed ID: 3081806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of cornstarch therapy in type III glycogen-storage disease.
    Gremse DA; Bucuvalas JC; Balistreri WF
    Am J Clin Nutr; 1990 Oct; 52(4):671-4. PubMed ID: 2403059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mitochondrial dysfunction in children with hepatic forms of glycogen storage disease].
    Kurbatova OV; Izmaĭlova TD; Surkov AN; Namazova-Baranova LS; Poliakova SI; Miroshkina LV; Semenova GF; Samokhina IV; Kapustina EIu; Dukhova ZN; Potapov AS; Petrichuk SV
    Vestn Ross Akad Med Nauk; 2014; (7-8):78-84. PubMed ID: 25563007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of pathways of glycogen synthesis and the dilution of the three-carbon pool with [U-13C]glucose.
    Katz J; Wals PA; Lee WN
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2103-7. PubMed ID: 2006149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of minimally invasive
    Turki A; Stockler S; Sirrs S; Salvarinova R; Ho G; Branov J; Rosen-Heath A; Bosdet T; Elango R
    Mol Genet Metab Rep; 2022 Jun; 31():100880. PubMed ID: 35585965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.